Net Cash Provided by (Used in) Operating Activities in GBP of TC BioPharm (Holdings) plc from 2022 to 2024

Taxonomy & unit
us-gaap: GBP and USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
TC BioPharm (Holdings) plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2022 to 2024.
  • TC BioPharm (Holdings) plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -£2.41M, a 17.3% increase year-over-year.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -£12.6M, a 19.2% decline from 2023.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -£10.5M, a 31% increase from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (GBP)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (GBP)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

TC BioPharm (Holdings) plc Quarterly Net Cash Provided by (Used in) Operating Activities (GBP)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -2.41M +503K +17.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -2.91M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15

TC BioPharm (Holdings) plc Annual Net Cash Provided by (Used in) Operating Activities (GBP)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -12.6M -2.02M -19.2% Jan 1, 2024 Dec 31, 2024 20-F 2025-05-09
2023 -10.5M +4.75M +31% Jan 1, 2023 Dec 31, 2023 20-F 2025-05-09
2022 -15.3M Jan 1, 2022 Dec 31, 2022 20-F 2025-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.